# DeepSeek V4.1 Flash / mol-k02

Original final answer, shared by both scoring rounds.

**Bottom line.** In this synthetic summary plot, the **50 kDa band has the stronger genetic specificity support**; the **75 kDa band has little or no genetic specificity support**. The supported band-level inference is: the 50 kDa signal is strongly dependent on the knocked-out target gene, whereas the 75 kDa signal is not. This is a relative, provisional inference, not proof of antibody specificity, because the figure is a quantification summary—not a raw blot—and the key claims (“equal loading,” “Validated KO”) are asserted rather than demonstrated.

**Evidence-to-inference-to-conclusion chain**

- **Evidence (E1):** The figure shows normalized band intensities (arbitrary units) from a synthetic knockout validation experiment. At 50 kDa, Control is high (~96) and Validated KO is low (~4). At 75 kDa, Control (~95) and Validated KO (~93) are nearly equal. The title states “equal loading.” The legend labels the conditions Control and Validated KO.
- **Inference 1:** The 50 kDa signal is strongly reduced in the KO condition relative to Control.
- **Inference 2:** The 75 kDa signal is essentially unchanged in the KO condition relative to Control.
- **Assumption required for genetic specificity:** The “Validated KO” is a true null for the intended target gene, equal loading is correct, the quantification is accurate, and both bars come from the same antibody under the same conditions.
- **Conclusion:** If those assumptions hold, the 50 kDa band is genetically dependent on the KO target, while the 75 kDa band is not. Therefore, the 50 kDa band is the stronger candidate for target-specific signal, and the 75 kDa band is presumptively non-specific, cross-reactive, or unrelated to the knocked-out gene.

**What the plot does and does not show.** The plot does not show raw blot images, band morphology, background, molecular-weight markers, replicate data, error bars, statistical tests, antibody concentrations, exposure times, or the KO strategy. It is a summary plot, so it cannot establish whether the 50 kDa bar represents a single clean band, a doublet, a degradation product, or a saturated signal. It also cannot show whether the 75 kDa band is a separate protein, a modified form of the target, or a loading-control-like signal. The y-axis is arbitrary, so absolute protein amounts are unknown.

**Key assumptions and why they matter**

1. **KO validity.** “Validated KO” must mean the target protein is absent at the protein level in the relevant cells/tissue. If validation was done only by PCR or sequencing, or by the same antibody being tested, the inference is weaker or circular.
2. **Equal loading.** If the KO lane contains less total protein, the 50 kDa reduction could be a loading artifact. The unchanged 75 kDa band argues against a global loading difference, but it does not prove equal loading if the 75 kDa signal is saturated or normalized.
3. **Antibody behavior.** The antibody must recognize the target epitope in a linear, non-saturated range. If the 50 kDa Control signal is saturated, the true KO reduction may be even larger; if the 50 kDa KO signal is at background, the ~4 units may be noise.
4. **Normalization.** The title says “equal loading,” implying normalization to total protein or a loading control. If the y-axis was normalized to the 75 kDa band itself, then the 75 kDa constancy is tautological, and the 50 kDa reduction is only relative to that band.
5. **Band identity.** The 50 kDa band must correspond to the intended target protein. The 75 kDa band must not be a target isoform or modification that escapes the KO.

**Alternative explanations**

- **Incomplete or hypomorphic KO.** If the KO is not a true null, residual target protein could persist. However, if the 50 kDa and 75 kDa bands came from the same gene, both should be reduced. The unchanged 75 kDa band therefore argues that it is not the target, unless the KO selectively affects only one isoform.
- **Off-target or secondary effect.** The 50 kDa band could be a non-target protein whose expression is downregulated because of KO toxicity, compensatory changes, or off-target CRISPR effects. Rescue experiments would test this.
- **Loading or normalization artifact.** If equal loading is false, or if the 50 kDa signal was normalized differently between lanes, the apparent reduction could be artifactual. The 75 kDa band’s stability makes a simple global loading difference less likely, but not impossible.
- **75 kDa as the true target.** This would require the KO to be incomplete, tissue-specific, or isoform-selective, or the antibody epitope to be outside the deleted region so a truncated protein persists. In a true full-gene null, a target-derived 75 kDa band should disappear.
- **50 kDa as a partner or downstream protein.** The antibody could be specific for a protein that is destabilized when the true target is knocked out. Then the 50 kDa band would be KO-dependent but not the target itself.
- **Antibody cross-reactivity.** The antibody may detect the target at 50 kDa and a distinct cross-reactive protein at 75 kDa. This is the most straightforward interpretation of a KO-dependent 50 kDa band and a KO-independent 75 kDa band.

**Orthogonal evidence that would strengthen the inference**

- **Raw blots with molecular-weight markers and replicates.** These would show whether the 50 kDa band is clean, whether the 75 kDa band is separate, and whether the KO reduction is reproducible. Proposed experiment: run n ≥ 3 independent lysates, show uncropped blots, and quantify with error bars and statistics.
- **Independent KO lines.** Use at least two independent sgRNAs, siRNA, or conditional KO strategies. If the 50 kDa band is lost in all true nulls and the 75 kDa band remains, the specificity claim is much stronger.
- **Rescue experiment.** Re-express the target in the KO background. If the 50 kDa band returns and the 75 kDa band does not change, the 50 kDa band is strongly supported as target-derived.
- **Multiple antibodies against different epitopes.** If two or more independent antibodies lose the 50 kDa band in KO, the target assignment is strengthened. If an antibody also detects the 75 kDa band, that band is likely cross-reactive or a modified form.
- **Mass spectrometry.** Excise the 50 kDa and 75 kDa bands from Control, digest, and identify proteins. If the 50 kDa band contains the target protein and the 75 kDa band does not, the inference is strongly supported. If the 75 kDa band also contains target protein, the KO may be incomplete or the 75 kDa band may be a modified/truncated form.
- **Independent target validation.** qPCR, targeted proteomics, or Western blot with a validated antibody should show loss of target mRNA/protein in the KO. If target protein is still present, the KO is not a true null.
- **Loading and specificity controls.** Total protein stain, GAPDH/actin, isotype control, peptide competition, and negative-control KO of an unrelated gene would address loading, background, and off-target effects.

**What would overturn the inference**

- If a true null KO made with an independent strategy still shows the 50 kDa band at wild-type levels, the 50 kDa band is not target-specific.
- If the 75 kDa band is identified as the target protein by mass spectrometry and the KO is incomplete or isoform-selective, the 75 kDa band could become the target candidate.
- If equal loading is demonstrably false, or if the 50 kDa reduction is lost after proper normalization, the main evidence for 50 kDa specificity collapses.
- If rescue fails to restore the 50 kDa band, the 50 kDa band may be a secondary/off-target effect rather than the target itself.

**Limits and uncertainty.** This is a synthetic teaching figure, and no unreported validation data are available. The plot provides only relative band intensities under asserted conditions. It cannot establish absolute antibody specificity, cannot prove the KO is a true null, and cannot identify the 75 kDa band. The strongest defensible statement is: **the 50 kDa band has stronger genetic specificity support than the 75 kDa band in this synthetic KO validation summary.** To convert that into a validated claim, use raw blots, independent KO/rescue experiments, orthogonal antibodies, and protein identification methods. Until then, treat the 50 kDa band as the candidate target signal and the 75 kDa band as presumptively non-specific.
